These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6670258)

  • 1. [alpha-Interferon indices in systemic lupus erythematosus and the effect of interferon therapy].
    Barinskiĭ IF; Alekberova ZS; Savinov VA; Pitenov VA; Kuznetsov VP
    Vopr Virusol; 1983; 28(6):733-6. PubMed ID: 6670258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of activated cytokine pathways in the blood of systemic lupus erythematosus, myositis, rheumatoid arthritis, and scleroderma patients.
    Higgs BW; Zhu W; Richman L; Fiorentino DF; Greenberg SA; Jallal B; Yao Y
    Int J Rheum Dis; 2012 Feb; 15(1):25-35. PubMed ID: 22324944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interferon reaction of leukocytes in diffuse connective tissue diseases].
    Pitenov VA; Etkind GV; Bektemirov TA; Alekberova ZS; Barinskiĭ IF
    Sov Med; 1976 Dec; (12):21-6. PubMed ID: 1013787
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of exogenous interferon and various interferon inducers on the indicators of general reactivity in systemic lupus erythematosus].
    Alekberova ZS; Barinskiĭ IF; Savinov VA; Pitenov VA; Kuznetsov VP
    Ter Arkh; 1980; 52(6):98-100. PubMed ID: 6157213
    [No Abstract]   [Full Text] [Related]  

  • 5. Interferon-induced 2'-5' adenylate synthetase in vivo and interferon production in vitro by lymphocytes from systemic lupus erythematosus patients with and without circulating interferon.
    Preble OT; Rothko K; Klippel JH; Friedman RM; Johnston MI
    J Exp Med; 1983 Jun; 157(6):2140-6. PubMed ID: 6189954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway.
    Higgs BW; Liu Z; White B; Zhu W; White WI; Morehouse C; Brohawn P; Kiener PA; Richman L; Fiorentino D; Greenberg SA; Jallal B; Yao Y
    Ann Rheum Dis; 2011 Nov; 70(11):2029-36. PubMed ID: 21803750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon production of vitro by leucocytes from patients with systemic lupus erythematosus and rheumatoid arthritis.
    Neighbour PA; Grayzel AI
    Clin Exp Immunol; 1981 Sep; 45(3):576-82. PubMed ID: 6175456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type I interferon as a biomarker in autoimmunity and viral infection: a leukocyte subset-specific analysis unveils hidden diagnostic options.
    Strauß R; Rose T; Flint SM; Klotsche J; Häupl T; Peck-Radosavljevic M; Yoshida T; Kyogoku C; Flechsig A; Becker AM; Dao KH; Radbruch A; Burmester GR; Lyons PA; Davis LS; Hiepe F; Grützkau A; Biesen R
    J Mol Med (Berl); 2017 Jul; 95(7):753-765. PubMed ID: 28357476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Circulating CD8 as an indicator of inflammatory rheumatic disease].
    Becker H; Paul E; Schaum S; Renelt M; Federlin K
    Immun Infekt; 1992 Feb; 20(1):6-9. PubMed ID: 1563757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The use of interferon in treating systemic lupus erythematosus].
    Egorova ON; Balabanova RM
    Ter Arkh; 1994; 66(12):45-6. PubMed ID: 7900044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbohydrate-deficient transferrin depends on disease activity in rheumatoid arthritis and systemic sclerosis.
    Gruszewska E; Chludzinska A; Chrostek L; Cylwik B; Gindzienska-Sieskiewicz E; Szmitkowski M; Sierakowski S
    Scand J Rheumatol; 2013; 42(3):203-6. PubMed ID: 23379548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble interleukin 2 receptor levels in serum and its relationship to T cell abnormality and clinical manifestations of the disease in patients with systemic lupus erythematosus.
    Raziuddin S; al-Janadi MA; al-Wabel AA
    J Rheumatol; 1991 Jun; 18(6):831-6. PubMed ID: 1680190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphokine production in rheumatoid arthritis and systemic lupus erythematosus.
    McKenna RM; Wilkins JA; Warrington RJ
    J Rheumatol; 1988 Nov; 15(11):1639-42. PubMed ID: 3148712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of cartilage oligomeric matrix protein are elevated in rheumatoid arthritis, but not in inflammatory rheumatic diseases such as psoriatic arthritis, reactive arthritis, Raynaud's syndrome, scleroderma, systemic lupus erythematosus, vasculitis and Sjögren's syndrome.
    Skoumal M; Haberhauer G; Feyertag J; Kittl EM; Bauer K; Dunky A
    Arthritis Res Ther; 2004; 6(2):73-4. PubMed ID: 15059267
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of serum from patients with systemic lupus erythematosus on the immune response of normal lymphocytes.
    Jarrett MP; Grayzel AI
    J Rheumatol; 1985 Feb; 12(1):81-6. PubMed ID: 3981521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A redundant epistatic interaction between IRF5 and STAT4 of the type I interferon pathway in susceptibility to lupus and rheumatoid arthritis.
    Kim K; Cho SK; Han TU; Kim JH; Kang SJ; Kang C; Bae SC
    Lupus; 2013 Nov; 22(13):1336-40. PubMed ID: 24014567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of high doses of exogenous interferon in systemic lupus erythematosus].
    Savinov VA; Alekberova ZS; Barinskiĭ IF; Bulanova TD; Kuznetsov VP
    Ter Arkh; 1981; 53(7):118-21. PubMed ID: 6170126
    [No Abstract]   [Full Text] [Related]  

  • 18. [Reactivation of the alpha 1-fetoprotein synthesis in systemic lupus erythematosus].
    Wollina U; Schulze M; Knopf B
    Z Hautkr; 1985 Jun; 60(11):902-7. PubMed ID: 2409682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A preliminary study of serum interferon in systemic lupus erythematosus and its significance.
    Shi SY; Feng SF; Wen YM; He LF; Huang YX
    Chin Med J (Engl); 1986 Mar; 99(3):229-34. PubMed ID: 3095051
    [No Abstract]   [Full Text] [Related]  

  • 20. Possible involvement of interferon alfa in the pathogenesis of fever in systemic lupus erythematosus.
    Kanayama Y; Kim T; Inariba H; Negoro N; Okamura M; Takeda T; Inoue T
    Ann Rheum Dis; 1989 Oct; 48(10):861-3. PubMed ID: 2818022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.